Tuesday, 26 October

07:30 – 08:15 Davos 2

Breakfast / Industry sponsored symposium

08:15 – 09:30 Davos 2

Session 1: Aortic Valve Disease

Chair: Felix C. Tanner, Zurich / Georg Nickenig, Bonn

Advanced imaging in aortic stenosis

Jeroen J. Bax, Leiden

TAVI in low and moderate risk patients

Thomas Pilgrim, Berne

Unresolved issues in TAVI

Stefan Toggweiler, Lucerne

The 2021 ESC Guidelines on valvular heart disease

Alec Vahanian, Paris

Panel discussion

09:30 – 10:00


10:00 – 11:30

Parallel Sessions

a) Mitral and Tricuspid Valve Disease

Davos 1

Chair: Giovanni Pedrazzini, Lugano / Michael Gatzoulis. London

  • Imaging the mitral valve
    Michel Zuber, Othmarsingen
  • Management of MR: surgical or percutaneous?
    Francesco Maisano, Milan
  • Tricuspid regurgitation: a new therapeutic target
    Georg Nickenig, Bonn
  • Panel discussion

b) Covid-19 and the Heart

Davos 2

Chair: Richard Grocott-Mason, London / Bernard Gersh, Rochester

  • The acute impact of Covid-19 on the cardiovascular system
    Susanna Price, London
  • Collateral damage of Covid-19
    Thomas F. Lüscher, London
  • The Long Covid syndrome
    Betty Raman, Oxford
  • From prevention to vaccination
    Milo Puhan, Zurich
  • Panel discussion
12:00 – 13:15

Lunch / Industry sponsored symposium

13:30 – 15:00 Davos 2

Session 3: Heart Failure I: Established and Novel Drugs

Chair: John Cleland, Glasgow / Giuseppe Rosano, London

From ACE-inhibition to mineralocorticoid receptor antagonism

Marc A. Pfeffer, Boston

Angiotensin receptor antagonism and neprilysin inhibition across the spectrum of ejection fractions in heart failure

Karl B. Swedberg, Gothenburg

SGLT2 inhibitors in heart failure: when and how to use?

Milton Packer, Dallas

Cyclic GMP activators: The VICTORIA trial

Burkart Pieske, Berlin

Cardiac-specific myosin activators: GALACTIC-HF

John Cleland, Glasgow

Panel discussion

15:00 – 15:15


15:15 – 16:00

Parallel Sessions

a) Meet the Expert Session: How to implement the 2021 ESC Guidelines in Heart Failure Algorithm for sequencing drug treatment in HFrEF

Davos 2

Moderators and cases: Marco Metra, Brescia / Christian Mueller, Basel / Roger Hullin, Lausanne

b) Meet the Expert Session: Imaging the Mitral Valve

Davos 1

Moderators and cases: Victoria Delgado, Leiden / Michel Zuber, Othmarsingen / Simon Stämpfli, Lucerne

16:00 – 17:00 Davos 2

Session 4: Heart Failure II: Open Issues in Heart Failure

Chair: Milton Packer, Dallas / Marc A. Pfeffer, Boston

The 2021 ESC Guidelines on heart failure

Marco Metra, Brescia

Clinical use of biomarkers in heart failure

Christian Müller, Basel

Artificial Intelligence in heart failure

Alan S. Maisel

Remote monitoring in heart failure

Gerd Hindricks, Leipzig

Panel discussion

17:00 – 17:15

Wrap Up / Closing Remarks